SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-028841
Filing Date
2019-08-05
Accepted
2019-08-05 17:22:14
Documents
82
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q chrs-10q_20190630.htm 10-Q 3285721
2 EX-10.1 chrs-ex101_146.htm EX-10.1 77633
3 EX-31.1 chrs-ex311_7.htm EX-31.1 16161
4 EX-31.2 chrs-ex312_6.htm EX-31.2 16297
5 EX-32.1 chrs-ex321_8.htm EX-32.1 10870
  Complete submission text file 0001564590-19-028841.txt   11429666

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT chrs-20190630.xml EX-101.INS 2717168
7 XBRL TAXONOMY EXTENSION SCHEMA chrs-20190630.xsd EX-101.SCH 63847
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE chrs-20190630_cal.xml EX-101.CAL 85906
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE chrs-20190630_def.xml EX-101.DEF 252191
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE chrs-20190630_lab.xml EX-101.LAB 484216
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE chrs-20190630_pre.xml EX-101.PRE 424822
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36721 | Film No.: 19999644
SIC: 2836 Biological Products, (No Diagnostic Substances)